NexgenRx Inc. NXG

TORONTO, ON / ACCESS Newswire / August 20, 2026 /NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2026, with revenues of $5,160,582, net income of $993,095 and EBITDA of ...

The Canadian market is experiencing a rise in yields that could influence equity performance, especially after a robust two-month rally. This environment presents both challenges and opportunities for investors, with penny stocks offering a unique avenue for potential growth. While the term "penny stocks" might seem outdated, these smaller or newer companies can provide significant upside when backed by strong financials and solid fundamentals.

TORONTO, ON / ACCESS Newswire / May 21, 2026 /NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing ...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

TORONTO, ON / ACCESS Newswire / April 17, 2026 /NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common ...

TORONTO, ON / ACCESS Newswire / March 31, 2026 /NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2025, with net income and EBITDA improving to $3,350,704 (an ...